Streetbeat News

Stock Prices

FUL

H.B. Fuller (NYSE:FUL) reported Q1 adjusted earnings of $0.67 per share, surpassing the consensus estimate of $0.64, a 21.82% increase from last year. However, sales of $810.42M fell short of the $825.03M estimate, marking a slight 0.15% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 8:06 pm

BCDA

BioCardia (NASDAQ:BCDA) reported Q4 earnings with a per-share loss of $(0.09), beating the $(0.11) estimate, marking an 18.18% improvement. However, their quarterly sales of $13.00K fell short of the $90.00K estimate by 85.56%, representing an 87.74% decrease from the previous year.

Portfolio Pulse from dijoy@benzinga.com

March 27, 2024 | 8:06 pm

DRRX

Durect Corporation (NASDAQ:DRRX) reported Q4 2023 earnings with a GAAP EPS of $(0.10), surpassing the $(0.33) estimate, and sales of $2.669M, exceeding the $2.477M estimate. However, this represents a 19.49% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 8:05 pm

ROP

Over the past 10 years, Roper Techs (NASDAQ:ROP) has produced an average annual return of 15.29%, outperforming the market by 4.54% annually. With a current market capitalization of $59.50 billion, a $1000 investment in ROP 10 years ago would now be worth $4,182.65. This showcases the significant impact of compounded returns on investment growth over time.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 8:00 pm

CPRT

Over the past 10 years, Copart (NASDAQ:CPRT) has significantly outperformed the market, yielding an average annual return of 28.75%. A $100 investment in CPRT a decade ago would now be worth $1,257.38. This showcases the impact of compounded returns on investment growth over time. Copart's current market capitalization stands at $55.56 billion.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 8:00 pm

NIO

XPEV

XPeng shares are trading lower, potentially in sympathy with NIO, which saw a decline after reducing its delivery outlook.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 7:54 pm

VERA

Vera Therapeutics' stock price increased following Guggenheim's decision to maintain a Buy rating and raise its price target from $27 to $56.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 7:53 pm

DIA

IWM

QQQ

SPY

Major stock indexes have experienced a rebound, recovering from a recent pullback in the market.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 7:52 pm

DIA

ENPH

FSLR

IWM

QQQ

RDDT

SPY

Stock indexes rebounded after recent declines, with notable movements in specific sectors and stocks. Reddit shares experienced a drop, while solar stocks, including Enphase Energy and First Solar, saw gains. Major ETFs like DIA, IWM, QQQ, and SPY also reflected the market's positive shift.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 7:52 pm

QCOM

Qualcomm has seen significant options trading activity, with a bullish sentiment from investors. Analysis of 24 trades reveals 62% bullish and 37% bearish expectations. The trading volume and open interest suggest a price target range between $115 and $200. Notable trades include a mix of calls and puts with varying sentiments and expiration dates. Qualcomm, a leader in wireless technology and chip design, has its stock price up 1.41% at $169.42, with potential overbought signals. Two market experts have set a consensus target price at $150, with Cantor Fitzgerald downgrading the stock to Neutral.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 7:45 pm